These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9783836)

  • 21. HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis.
    Berntson L; Nordal E; Aalto K; Peltoniemi S; Herlin T; Zak M; Nielsen S; Rygg M;
    J Rheumatol; 2013 May; 40(5):725-31. PubMed ID: 23547219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-B27 antigen and rheumatoid arthritis.
    Jajić Z; Jajić I; Jajić I
    Acta Med Iugosl; 1991; 45(3):195-202. PubMed ID: 1950638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis of reactive salmonella arthritis.
    Leirisalo-Repo M; Helenius P; Hannu T; Lehtinen A; Kreula J; Taavitsainen M; Koskimies S
    Ann Rheum Dis; 1997 Sep; 56(9):516-20. PubMed ID: 9370874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of disease outcome in Salmonella-infected patients by HLA-B27.
    Ekman P; Kirveskari J; Granfors K
    Arthritis Rheum; 2000 Jul; 43(7):1527-34. PubMed ID: 10902756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction.
    Kirveskari J; Kellner H; Wuorela M; Soini H; Frankenberger B; Leirisalo-Repo M; Weiss EH; Granfors K
    Br J Rheumatol; 1997 Feb; 36(2):185-9. PubMed ID: 9133926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.
    Zeidler H; Hudson AP
    Curr Rheumatol Rep; 2021 Jul; 23(7):53. PubMed ID: 34196842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile associated reactive arthritis in an HLA-B27 positive female: report and literature review.
    Mermel LA; Osborn TG
    J Rheumatol; 1989 Jan; 16(1):133-5. PubMed ID: 2654390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection.
    Nickerson CL; Luthra HS; Savarirayan S; David CS
    Hum Immunol; 1990 Aug; 28(4):382-96. PubMed ID: 2391253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil function and HLA-B27.
    Repo H; Leirisalo M; Koivuranta P; Osterman T; Kiistala U; Gahmberg CG; Vapaatalo H; Tiilikainen A; Laitinen O
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune functions and inflammatory reactions in HLA-B27 positive subjects.
    Tertti R; Toivanen P
    Ann Rheum Dis; 1991 Oct; 50(10):731-4. PubMed ID: 1958101
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-B27 in French patients with rheumatoid arthritis.
    Saraux A; Guedes C; Allain J; Valls I; Baron D; Youinou P; Le Goff P
    Scand J Rheumatol; 1997; 26(4):269-71. PubMed ID: 9310106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA frequencies in HLA-B27 negative patients with reactive arthritis.
    Laivoranta S; Ilonen J; Tuokko J; Luukkainen R; Toivanen A
    Clin Exp Rheumatol; 1995; 13(5):637-40. PubMed ID: 8575144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.
    Tuokko J; Reijonen H; Ilonen J; Anttila K; Nikkari S; Möttönen T; Yli-Kerttula U; Toivanen A
    Ann Rheum Dis; 1997 Jan; 56(1):37-40. PubMed ID: 9059139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria.
    García F; Marina A; Albar JP; López de Castro JA
    Tissue Antigens; 1997 Jan; 49(1):23-8. PubMed ID: 9027961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-B27 and disease: a consequence of inadvertent antigen presentation?
    Benjamin R; Parham P
    Rheum Dis Clin North Am; 1992 Feb; 18(1):11-21. PubMed ID: 1561398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HLA-B27 in the families of probands with arthritis after acute respiratory tract disease].
    Hrncírová L; Klabusay L; Vitulová V
    Vnitr Lek; 1991; 37(9-10):776-80. PubMed ID: 1771811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and serological characterization of Chlamydia-induced arthritis].
    Wollenhaupt HJ; Schneider C; Zeidler H; Krech T; Kuntz BM
    Dtsch Med Wochenschr; 1989 Dec; 114(50):1949-54. PubMed ID: 2598790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.